Verona Pharma (VRNA) shares have risen the last three weeks strongly and has seen unusual 5500 December $30 calls buy to open on 7/16 and 7/17. On 6/27 the FDA granted approval to a treatment from Verona Pharma for a chronic lung disease that commonl...
